GlobalData Market Research Reports





RSS Sort By :
TITLE Price Buy Now More options

Asia Pacific Ethylbenzene Industry Outlook to 2016 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned PlantsSummaryGlobalData’s report, Asia Pacific Ethylbenzene ...

$ 3500


Europe Anesthesia and Respiratory Devices Market Outlook to 2018 - Respiratory Devices, Respiratory Measurement Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and Others Summary GlobalData’s new report, “E

$ 3500


Middle East and Africa Anesthesia and Respiratory Devices Market Outlook to 2018 - Respiratory Devices, Respiratory Measurement Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and Others Summary GlobalData’

$ 3500


GlobalData has released its medical device report, MediPoint: Transcatheter Aortic Valve Replacement - Current and Future Players. The report is a vital source of up-to-date information with in-depth analysis on the companies in the ra...

$ 3500


Fluzone High-Dose - (Seasonal Influenza Vaccine) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Fluzone High-Dose - (Seasonal Influenza Vaccine) Forecast and Market Analysis”. Seasonal

$ 3495


Afluria (Seasonal Influenza Vaccines) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Afluria (Seasonal Influenza Vaccines) Forecast and Market Analysis”. Seasonal Influenza is a respira

$ 3495


Influvac (Seasonal Influenza Vaccine) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Influvac (Seasonal Influenza Vaccine) Forecast and Market Analysis”. Seasonal Influenza is a respira

$ 3495


Fluarix (Seasonal Influenza Vaccine) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Fluarix (Seasonal Influenza Vaccine) Forecast and Market Analysis”. Seasonal Influenza is a respirato

$ 3495


Fluvirin (Seasonal Influenza Vaccine) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Fluvirin (Seasonal Influenza Vaccine) Forecast and Market Analysis”. Seasonal Influenza is a respira

$ 3495


FluMist (Seasonal Influenza Vaccines) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “FluMist (Seasonal Influenza Vaccines) Forecast and Market Analysis”. Seasonal Influenza is a respira

$ 3495


Fluad (Seasonal Influenza Vaccines) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Fluad (Seasonal Influenza Vaccines) Forecast and Market Analysis”. Seasonal Influenza is a respiratory

$ 3495


Vaxigrip (Seasonal Influenza Vaccines) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Vaxigrip (Seasonal Influenza Vaccines) Forecast and Market Analysis”. Seasonal Influenza is a respi

$ 3495


Optaflu (Seasonal Influenza Vaccine) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Optaflu (Seasonal Influenza Vaccine) Forecast and Market Analysis”. Seasonal Influenza is a respirato

$ 3495


Agrippal (Seasonal Influenza Vaccine) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Agrippal (Seasonal Influenza Vaccine) Forecast and Market Analysis”. Seasonal Influenza is a respira

$ 3495


FluBlok (Seasonal Influenza Vaccines) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, FluBlok (Seasonal Influenza Vaccines) Forecast and Market Analysis. Seasonal Influenza is a respirato

$ 3495


ASP7374 (Seasonal Influenza Vaccines) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “ASP7374 (Seasonal Influenza Vaccines) Forecast and Market Analysis”. Seasonal Influenza is a respira

$ 3495


Influenza VLP Vaccine (Seasonal Influenza Vaccines) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Influenza VLP Vaccine (Seasonal Influenza Vaccines) Forecast and Market Analysis”. Sea

$ 3495


Cimzia (Rheumatoid Arthritis) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Cimzia (Rheumatoid Arthritis) Forecast and Market Analysis. The RA market is currently very dynamic, with the

$ 3495


Orencia (Rheumatoid Arthritis) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Orencia (Rheumatoid Arthritis) Forecast and Market Analysis. The RA market is currently very dynamic, with t

$ 3495


Actemra (Rheumatoid Arthritis) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Actemra (Rheumatoid Arthritis) Forecast and Market Analysis. The RA market is currently very dynamic, with t

$ 3495

Live Chat Support
Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441
Subscription Option

Use our subscription option and keep yourself updated about the latest from GlobalData. We have market research reports of all sectors covered by the GlobalData; you can access and utilize them at economical budgets.

More about our Subscription option
Email Alerts

Get Email alerts about market research reports from industries and publishers of your interest:

Live Chat
Live Chat by Comm100